INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 126 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $729,000 | -6.8% | 195,406 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $782,000 | -64.4% | 195,406 | -50.5% | 0.00% | 0.0% |
Q3 2018 | $2,194,000 | +177.0% | 394,644 | +95.2% | 0.00% | 0.0% |
Q2 2018 | $792,000 | -8.2% | 202,165 | +10.3% | 0.00% | 0.0% |
Q1 2018 | $863,000 | +6.9% | 183,275 | -6.2% | 0.00% | 0.0% |
Q4 2017 | $807,000 | -62.4% | 195,382 | -42.3% | 0.00% | 0.0% |
Q3 2017 | $2,146,000 | +51.3% | 338,476 | +87.2% | 0.00% | 0.0% |
Q2 2017 | $1,418,000 | -7.0% | 180,825 | -21.5% | 0.00% | 0.0% |
Q1 2017 | $1,525,000 | -10.0% | 230,338 | -5.6% | 0.00% | 0.0% |
Q4 2016 | $1,694,000 | -39.3% | 244,039 | -18.5% | 0.00% | -50.0% |
Q3 2016 | $2,792,000 | -0.7% | 299,578 | -1.5% | 0.00% | 0.0% |
Q2 2016 | $2,811,000 | +28.8% | 304,169 | +21.4% | 0.00% | 0.0% |
Q1 2016 | $2,182,000 | +29.6% | 250,461 | 0.0% | 0.00% | +100.0% |
Q4 2015 | $1,683,000 | +12.0% | 250,461 | -3.7% | 0.00% | 0.0% |
Q3 2015 | $1,503,000 | -34.8% | 260,051 | -7.9% | 0.00% | -50.0% |
Q2 2015 | $2,304,000 | +29.7% | 282,362 | +29.7% | 0.00% | +100.0% |
Q1 2015 | $1,777,000 | -11.1% | 217,735 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $1,999,000 | -32.4% | 217,735 | -27.4% | 0.00% | -50.0% |
Q3 2014 | $2,955,000 | -61.0% | 300,027 | -57.2% | 0.00% | -60.0% |
Q2 2014 | $7,585,000 | – | 701,634 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Round Table Services, LLC | 129,500 | $1,207,000 | 0.72% |
STONERIDGE INVESTMENT PARTNERS LLC | 252,376 | $2,352,000 | 0.34% |
Bellevue Group AG | 155,000 | $1,445,000 | 0.26% |
WASATCH ADVISORS LP | 1,861,553 | $17,350,000 | 0.26% |
Blue Clay Capital Management, LLC | 13,000 | $121,000 | 0.14% |
Virtus ETF Advisers LLC | 24,058 | $224,000 | 0.11% |
EMERALD ADVISERS, LLC | 203,737 | $1,899,000 | 0.08% |
Vident Investment Advisory, LLC | 63,383 | $591,000 | 0.08% |
Thomas J. Herzfeld Advisors, Inc. | 15,000 | $140,000 | 0.08% |
GSA CAPITAL PARTNERS LLP | 94,400 | $880,000 | 0.05% |